Table 2 Baseline characteristics of patients
Control (N, %) | Intervention (N, %) | p-value | |
|---|---|---|---|
Total | 916 | 161 | |
Male sex | 457 (50.1) | 72 (44.7) | 0.203 |
Age | |||
0–14 years | 172 (18.8) | 27 (16.8) | 0.545 |
15–34 years | 410 (44.8) | 76 (47.2) | 0.565 |
≥35 years | 333 (36.4) | 57 (35.4) | 0.817 |
Unknown | 1 (0.1) | 1 (0.6) | |
TB category | |||
I (any new case) | 671 (73.3) | 130 (80.7) | 0.051 |
II (previously treated TB/TB meningitis) | 135 (14.8) | 14 (8.7) | 0.039* |
III (children under 8) | 107 (11.7) | 17 (10.6) | 0.671 |
Unknown | 3 (0.3) | 0 (0) | |
Pulmonary disease | 650 (71.0) | 120 (74.5) | 0.601 |
HIV status | |||
Reactive | 707 (77.4) | 111 (68.9) | 0.021* |
Non-reactive | 184 (20.2) | 47 (29.2) | 0.010* |
Test not done | 18 (2.0) | 2 (1.2) | 0.755 |
Unknown | 4 (0.4) | 1 (0.6) | |
On HIV treatment | 521 (73.7) | 90 (81.1) | 0.160 |